TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Takara Bio Europe AB
Closing information (x1000 NOK)
Closing information | 2020/12 | 2019/12 | 2018/12 |
Turnover |
31,930
|
38,209
|
39,480 |
Financial expenses |
1,147
|
850
|
1,629 |
Earnings before taxes |
-6,269
|
-8,317
|
-11,122 |
EBITDA |
-4,634
|
-7,171
|
-8,827 |
Total assets |
47,114
|
31,748
|
40,292 |
Current assets |
23,297
|
20,349
|
27,894 |
Current liabilities |
8,084
|
5,902
|
9,529 |
Equity capital |
28,911
|
16,797
|
9,383 |
- share capital |
2,328
|
2,100
|
2,169 |
Employees (average) |
28
|
26
|
27 |
Financial ratios
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Solvency |
61.4%
|
52.9%
|
23.3% |
Turnover per employee |
1,140
|
1,470
|
1,462 |
Profit as a percentage of turnover |
-19.6%
|
-21.8%
|
-28.2% |
Return on assets (ROA) |
-10.9%
|
-23.5%
|
-23.6% |
Current ratio |
288.2%
|
344.8%
|
292.7% |
Return on equity (ROE) |
-21.7%
|
-49.5%
|
-118.5% |
Change turnover |
-10,415
|
-24
|
1,007 |
Change turnover % |
-25%
|
0%
|
3% |
Chg. No. of employees |
2
|
-1
|
-4 |
Chg. No. of employees % |
8%
|
-4%
|
-13% |
Total value of public sale
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.